Yoles; Ester

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yoles; Ester.The latest application filed is for "modified anti-pd-l1 antibody and methods and uses for treating a neurodegenerative disease".

Company Profile

3.8.14

Yoles; Ester - Beit-Gamliel IL
Yoles; Ester - Nahal Soreq IL
Yoles; Ester - Moshav Beit Gamliel IL
Yoles; Ester - Rehovot IL
Yoles; Ester - D.N. Nahal Soreq IL
Yoles; Ester - D.N. Nahal Sorek IL
Yoles; Ester - Nahal Sorek IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified anti-PD-L1 Antibody and Methods and Uses for Treating a Neurodegenerative Disease App 20210221893 - Yoles; Ester ; et al.	2021-07-22
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerative disease Grant 10,995,141 - Yoles , et al. May 4, 2	2021-05-04
Modified anti-PD-L1 Antibody and Methods and Uses for Treating a Neurodegenerative Disease App 20200332011 - Yoles; Ester ; et al.	2020-10-22
Human monocyte sub-population for treatment of eye diseases and disorders Grant 10,188,679 - Eisenbach-Schwartz , et al. Ja	2019-01-29
Vaccine and method for treatment of neurodegenerative diseases Grant 9,517,256 - Eisenbach-Schwartz , et al. December 13, 2	2016-12-13
Human Monocyte Sub-Population for Treatment of Eye Diseases and Disorders App 20160166612 - EISENBACH-SCHWARTZ; Michal ; et al.	2016-06-16
Human monocyte sub-population for treatment of central nervous system injury Grant 9,314,483 - Eisenbach-Schwartz , et al. April 19, 2	2016-04-19
Cellular Blood Markers For Early Diagnosis Of Als And For Als Progression App 20150209404 - EISENBACH-SCHWARTZ; Michal ; et al.	2015-07-30
Cellular Markers For Diagnosis Of Alzheimer's Disease And For Alzheimer's Disease Progression App 20150057176 - Eisenbach-Schwartz; Michal ; et al.	2015-02-26
Human Monocyte Sub-population For Treatment Of Central Nervous System Injury App 20140363411 - Eisenbach-Schwartz; Michal ; et al.	2014-12-11
Vaccine and method for treatment of neurodegenerative diseases Grant 8,828,404 - Eisenbach-Schwartz , et al. September 9, 2	2014-09-09
Vaccine And Method For Treatment Of Neurodegenerative Diseases App 20140134196 - EISENBACH-SCHWARTZ; Michal ; et al.	2014-05-15
Cellular Blood Markers For Early Diagnosis Of Als And For Als Progression App 20130230499 - Eisenbach-Schwartz; Michal ; et al.	2013-09-05
Vaccine And Method For Treatment Of Neurodegenerative Diseases App 20110206706 - Eisenbach-Schwartz; Michal ; et al.	2011-08-25
Poly-Glu,Tyr for neuroprotective therapy Grant 7,399,740 - Eisenbach-Schwartz , et al. July 15, 2	2008-07-15
Vaccine And Method For Treatment Of Neurodegenerative Diseases App 20080085269 - Eisenbach-Schwartz; Michal ; et al.	2008-04-10
Use of poly-Glu,Tyr for neuroprotective therapy Grant 6,835,711 - Eisenbach-Schwartz , et al. December 28, 2	2004-12-28
Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease App 20040253218 - Eisenbach-Schwartz, Michal ; et al.	2004-12-16
Poly-Glu, Tyr for neuroprotective therapy App 20040248802 - Eisenbach-Schwartz, Michal ; et al.	2004-12-09
Use of poly-Glu,Tyr and T cells treated therewith for neuroprotective therapy App 20030003082 - Eisenbach-Schwartz, Michal ; et al.	2003-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.